-
1
المؤلفون: Konstantinos Leventogiannis, Vasiliki Lygoura, Anastasia Michail, Anna Samakidou, Nikolaos K. Gatselis, Evangelos J. Giamarellos-Bourboulis, Stella Gabeta, Efthymia Petinaki, Marianna Vlychou, Sarah P. Georgiadou, Aggelos Stefos, George N. Dalekos, George Ntaios, George Giannoulis
المصدر: European Journal of Internal Medicine
مصطلحات موضوعية: Male, BMI, body mass index, medicine.medical_treatment, 030204 cardiovascular system & hematology, chemistry.chemical_compound, 0302 clinical medicine, Intubation, 030212 general & internal medicine, Respiratory system, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2-related, COVID-19, coronavirus disease 2019, Respiratory Distress Syndrome, LDH, lactate dehydrogenase, Mortality rate, Middle Aged, Tocilizumab, IVIG, intravenous infusions of γ-globulins, Treatment Outcome, Anakinra, CRP, C-reactive protein, Female, Original Article, Respiratory Insufficiency, JAK, Janus kinase, medicine.drug, medicine.medical_specialty, Secondary infection, TNF-α, tumor necrosis factor-α, sHLH, haemophagocytic lymphohistiocytosis, 03 medical and health sciences, Internal medicine, Internal Medicine, medicine, Humans, RCTs, randomized controlled trials, Adverse effect, Aged, IL-6, SARS-CoV-2, IL-1, business.industry, COVID-19, HR, hazard ratio, IL, interleukin, MAS, macrophage activation syndrome, OR, odds ratio, Interleukin 1 Receptor Antagonist Protein, chemistry, Respiratory failure, business